Pegcetacoplan Safety: Panel Recap

Related

• 

  Results from Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity

  Rishi P. Singh, MD

  Updates from the Field

  2024

• 

  Subretinal Implantation of a Bioengineered Embryonic Stem Cell-Derived Retinal Pigment Epithelium Monolayer in Dry Age-Related

  Amir H Kashani, MD PhD

  Updates from the Field

  2018

• 

  Impact of Baseline Imbalances on the Efficacy of Pegcetacoplan for the Treatment of GA: A Post Hoc Analysis of OAKS, DERBY, and FILLY

  Sunir J. Garg, MD, FACS, FASRS

  Updates from the Field

  2022